文献速递乳腺癌放疗放疗物理与技术

保乳术后全乳放疗中瘤床加量的使用趋势与相关因素

Use of a Radiation Tumor Bed Boost After Breast-Conserving Surgery and Whole-Breast Irradiation: Time Trends and Correlates.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2020-08-06

基于2012—2016年美国国家癌症数据库380,387例早期乳腺癌保乳术后接受全乳放疗的患者,76.7%接受了瘤床加量。瘤床加量使用率随时间下降(79.2%→76.6%→74.7%,P<.001),常规分割组下降而大分割组上升(55.5%→65.1%,P<.001)。

要点

  • 保乳术后全乳放疗患者中76.7%接受了瘤床加量。
  • 整体瘤床加量使用率从2012-2013年的79.2%降至2015-2016年的74.7%。
  • 大分割放疗中瘤床加量使用率上升,常规分割中下降。

核心结论

  • 瘤床加量使用率总体随时间下降,与切缘指南发布相吻合,但大分割放疗患者中瘤床加量使用率上升。

研究设计与样本

  • 回顾性分析美国国家癌症数据库2012至2016年诊断的早期乳腺癌保乳术后接受全乳放疗的患者,共380,387例。

主要发现

  • 76.7%的患者接受了瘤床加量;整体使用率从2012-2013年的79.2%降至2014年的76.6%和2015-2016年的74.7%(P<.001)。
  • 常规分割全乳放疗中瘤床加量使用率从2012-2013年的84.9%降至2014年的83.5%和2015-2016年的82.3%(P<.001)。
  • 大分割全乳放疗中瘤床加量使用率从2012-2013年的55.5%升至2014年的60.7%和2015-2016年的65.1%(P<.001)。
  • 大分割放疗中,15次分割者瘤床加量使用率高于16次分割者(76.8% vs 59.1%,P<.001)。

关键数值与推荐

  • 年龄>70岁且切缘阴性低危患者中大分割放疗的瘤床加量使用率亦呈上升趋势。

临床怎么用

  • 分析瘤床加量使用趋势时需考虑分割方案这一关键变量,大分割放疗中瘤床加量使用增加而常规分割中减少。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We sought to evaluate time trends and correlates of the use of a radiation tumor bed boost (TBB) after breast-conserving surgery and either conventional or hypofractionated whole-breast irradiation (CWBI or HWBI) for patients with early stage breast cancer. METHODS AND MATERIALS: The National Cancer Database was queried for patients diagnosed between 2012 and 2016. We evaluated the utilization of TBB before and after publication of the Society of Surgical Oncology-American Society for Radiation Oncology margin guidelines in relation to sociodemographic variables, treatment facility, tumor characteristics, and whole-breast fractionation. RESULTS: The population included 380,387 patients, of whom 76.7% received a TBB. Utilization of TBB decreased over time (2012-2013: 79.2%; 2014: 76.6%; 2015-2016: 74.7%; P < .001); this was seen for most subgroups evaluated. Rates of TBB differed by facility type and region. There was a decrease in TBB use in patients treated with CWBI over time (2012-2013: 84.9%; 2014: 83.5%; 2015-2016: 82.3%; P < .001) but an increase among patients treated with HWBI (2012-2013: 55.5%; 2014: 60.7%; 2015-2016: 65.1%; P < .001); this was also seen for low-risk patients (age >70 years, negative margins). Among patients undergoing HWBI, TBB was more frequently used when 15 fractions were used compared with 16 fractions (76.8% vs 59.1%; P < .001). CONCLUSIONS: The use of TBB decreased over time, coinciding with the publication of new margin guidelines, for patients receiving CWBI and those with negative margins, but TBB use increased for patients treated with HWBI. Hence, fractionation regimen is a critical variable in analyzing changes over time in the practice patterns of TBB.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Tom MC, Sittenfeld SMC, Shah C, et al. Use of a Radiation Tumor Bed Boost After Breast-Conserving Surgery and Whole-Breast Irradiation: Time Trends and Correlates. Int J Radiat Oncol Biol Phys. 2020. PMID: 32768561. doi:10.1016/j.ijrobp.2020.07.2624

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。